Potential cost-effectiveness of individualized medicine in prodromal Alzheimer’s disease by demographic, clinical and cerebrospinal fluid proteomics factors

Ron Handels, Kirsten Wesenhagen, Betty Tijms, Charlotte Teunissen, Pieter Jelle Visser, Linus Jönsson
doi: https://doi.org/10.1101/2023.01.24.23284478

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

http://www.ipecad.org/open-source-model

Back to top
Posted January 28, 2023.
Download PDF
Data/Code
Email
Potential cost-effectiveness of individualized medicine in prodromal Alzheimer’s disease by demographic, clinical and cerebrospinal fluid proteomics factors
Ron Handels, Kirsten Wesenhagen, Betty Tijms, Charlotte Teunissen, Pieter Jelle Visser, Linus Jönsson
medRxiv 2023.01.24.23284478; doi: https://doi.org/10.1101/2023.01.24.23284478
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area